Aldosterone Excess Impairs First Phase Insulin Secretion in Primary Aldosteronism

被引:75
作者
Fischer, Evelyn [1 ]
Adolf, Christian [1 ]
Pallauf, Anna [1 ]
Then, Cornelia [1 ]
Bidlingmaier, Martin [1 ]
Beuschlein, Felix [1 ]
Seissler, Jochen [1 ,2 ,3 ]
Reincke, Martin [1 ]
机构
[1] Klinikum Univ Munchen, Med Klin & Poliklin 4, D-80336 Munich, Germany
[2] Univ Munich, Clin Cooperat Grp Diabet, D-80336 Munich, Germany
[3] Helmholtz Zentrum Munchen, D-80336 Munich, Germany
关键词
GERMAN CONNS REGISTRY; HOMEOSTASIS MODEL ASSESSMENT; BETA-CELL FUNCTION; METABOLIC SYNDROME; PRIMARY HYPERALDOSTERONISM; PLASMA-ALDOSTERONE; GLUCOSE-TOLERANCE; ADRENAL-STEROIDS; RISK-FACTORS; HYPERTENSION;
D O I
10.1210/jc.2012-3934
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context: Primary aldosteronism (PA) represents the most frequent cause of secondary arterial hypertension. Conflicting data have been published regarding the effect of aldosterone excess on glucose metabolism. Objective: Our aim was to analyze insulin sensitivity and beta-cell function in a cohort of PA patients. Prospective follow-up investigations were performed in a subgroup of patients before and after adrenalectomy to assess the metabolic outcome. Design: Oral glucose tolerance test, combined intravenous glucose tolerance test, hyperinsulinemic-euglycemic glucose clamp test, and arginine test were carried out after a 12-hour fasting period. Patients: Twenty-two consecutive patients with both unilateral aldosterone-producing adenoma and bilateral idiopathic adrenal hyperplasia were recruited through the Munich center of the German Conn's Registry. The control group of patients with essential hypertension (n = 11) of corresponding age and body mass index was recruited from our hypertension unit. Anormotensive cohort (n = 11) served as a further control group. Results: At baseline, first-phase insulin reaction in intravenous glucose tolerance test was significantly reduced in patients with PA as compared to normal controls(36.0 [24.0; 58.7] vs 90.1 [52.6; 143.8] mu U/mL, P = .031) and lower in comparison to essential hypertension without reaching statistical significance (53.2 [30.8; 73.3] mu U/mL, P = .123). The study was repeated 6 months after unilateral adrenalectomy in 9 consecutive patients with aldosterone-producing adenoma. At this time point, blood pressure had been normalized in most of the patients while body mass index remained unchanged (26.9 [25.5; 37.6] vs 27.5 [25.1; 35.6] kg/m(2), P = .401). First-phase insulin reaction in response to glucose significantly increased at follow-up (from 36.0 [25.5; 58.7] to 48.5 [40.4; 95.2] mu U/mL, P = .038, n = 9). In contrast, insulin sensitivity and response to iv arginine did not differ before and after adrenalectomy. Conclusion: Aldosterone excess has a direct negative effect on beta-cell function in patients with PA. After adrenalectomy, glucose-induced first-phase insulin secretion improves significantly in the patients.
引用
收藏
页码:2513 / 2520
页数:8
相关论文
共 52 条
[11]   Insulin resistance and hyperinsulinemia are related to plasma aldosterone levels in hypertensive patients [J].
Coliussi, GianLuca ;
Catena, Cristiana ;
Lapenna, Roberta ;
Nadalini, Elisa ;
Chiuch, Alessandra ;
Sechi, Leonareo A. .
DIABETES CARE, 2007, 30 (09) :2349-2354
[12]   The effect of aldosterone on glucose metabolism [J].
Corry, DB ;
Tuck, ML .
CURRENT HYPERTENSION REPORTS, 2003, 5 (02) :106-109
[13]   Hyperinsulinemia as an independent risk factor for ischemic heart disease [J].
Despres, JP ;
Lamarche, B ;
Mauriege, P ;
Cantin, B ;
Dagenais, GR ;
Moorjani, S ;
Lupien, PJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (15) :952-957
[14]   Characterization of insulin secretion and resistance in type 2 diabetes of adolescents [J].
Druet, C ;
Tubiana-Rufi, N ;
Chevenne, D ;
Rigal, O ;
Polak, M ;
Levy-Marchal, C .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (02) :401-404
[15]   POWER AND SAMPLE-SIZE CALCULATIONS - A REVIEW AND COMPUTER-PROGRAM [J].
DUPONT, WD ;
PLUMMER, WD .
CONTROLLED CLINICAL TRIALS, 1990, 11 (02) :116-128
[16]   The metabolic syndrome [J].
Eckel, RH ;
Grundy, SM ;
Zimmet, PZ .
LANCET, 2005, 365 (9468) :1415-1428
[17]   Prevalence and characteristics of the metabolic syndrome in primary aldosteronism [J].
Fallo, F ;
Veglio, F ;
Bertello, C ;
Sonino, N ;
Della Mea, P ;
Ermani, M ;
Rabbia, F ;
Federspil, G ;
Mulatero, P .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (02) :454-459
[18]   Primary Aldosteronism and Metabolic Syndrome [J].
Fallo, F. ;
Pilon, C. ;
Urbanet, R. .
HORMONE AND METABOLIC RESEARCH, 2012, 44 (03) :208-214
[19]   Adiponectin and insulin sensitivity in primary aldosteronism [J].
Fallo, Francesco ;
Della Mea, Paolo ;
Sonino, Nicoletta ;
Bertello, Chiara ;
Ermani, Mario ;
Vettor, Roberto ;
Veglio, Franco ;
Mulatero, Paolo .
AMERICAN JOURNAL OF HYPERTENSION, 2007, 20 (08) :855-861
[20]   Commentary on the Endocrine Society Practice Guidelines: Consequences of adjustment of antihypertensive medication in screening of primary aldosteronism [J].
Fischer, Evelyn ;
Beuschlein, Felix ;
Bidlingmaier, Martin ;
Reincke, Martin .
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2011, 12 (01) :43-48